BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21648177)

  • 1. Nimesulide: patients still exposed to a risk of severe hepatitis.
    Prescrire Int; 2011 May; 20(116):125-6. PubMed ID: 21648177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nimesulide and COX-2 inhibitors.
    Bakhle YS
    Lancet; 1999 Aug; 354(9180):772. PubMed ID: 10475213
    [No Abstract]   [Full Text] [Related]  

  • 3. Nimesulide-induced acute hepatitis.
    Sbeit W; Krivoy N; Shiller M; Farah R; Cohen HI; Struminger L; Reshef R
    Ann Pharmacother; 2001 Sep; 35(9):1049-52. PubMed ID: 11573855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems.
    Lapeyre-Mestre M; de Castro AM; Bareille MP; Del Pozo JG; Requejo AA; Arias LM; Montastruc JL; Carvajal A
    Fundam Clin Pharmacol; 2006 Aug; 20(4):391-5. PubMed ID: 16867024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimesulide-induced hepatitis and acute liver failure.
    Weiss P; Mouallem M; Bruck R; Hassin D; Tanay A; Brickman CM; Farfel Z; Bar-Meir S
    Isr Med Assoc J; 1999 Oct; 1(2):89-91. PubMed ID: 10731303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders.
    Asero R
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):554-8. PubMed ID: 10400483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nimesulide-induced acute hepatitis: evidence from six cases.
    Van Steenbergen W; Peeters P; De Bondt J; Staessen D; Büscher H; Laporta T; Roskams T; Desmet V
    J Hepatol; 1998 Jul; 29(1):135-41. PubMed ID: 9696502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug.
    Suleyman H; Cadirci E; Albayrak A; Halici Z
    Curr Med Chem; 2008; 15(3):278-83. PubMed ID: 18333314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal hepatoxicity secondary to nimesulide.
    Merlani G; Fox M; Oehen HP; Cathomas G; Renner EL; Fattinger K; Schneemann M; Kullak-Ublick GA
    Eur J Clin Pharmacol; 2001 Jul; 57(4):321-6. PubMed ID: 11549211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case-control study in Italy.
    Donati M; Conforti A; Lenti MC; Capuano A; Bortolami O; Motola D; Moretti U; Vannacci A; Rafaniello C; Vaccheri A; Arzenton E; Bonaiuti R; Sportiello L; Leone R;
    Br J Clin Pharmacol; 2016 Jul; 82(1):238-48. PubMed ID: 26991794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serious liver injury induced by Nimesulide: an international collaborative study.
    Bessone F; Hernandez N; Mendizabal M; Ridruejo E; Gualano G; Fassio E; Peralta M; Fainboim H; Anders M; Tanno H; Tanno F; Parana R; Medina-Caliz I; Robles-Diaz M; Alvarez-Alvarez I; Niu H; Stephens C; Colombato L; Arrese M; Reggiardo MV; Ono SK; Carrilho F; Lucena MI; Andrade RJ
    Arch Toxicol; 2021 Apr; 95(4):1475-1487. PubMed ID: 33759010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug safety issues of nimesulide in China--nimesulide-induced liver injury.
    Wang Y; Zeng Y; Xu F
    Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):778-9. PubMed ID: 21714032
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse drug reactions related to the use of NSAIDs with a focus on nimesulide: results of spontaneous reporting from a Northern Italian area.
    Conforti A; Leone R; Moretti U; Mozzo F; Velo G
    Drug Saf; 2001; 24(14):1081-90. PubMed ID: 11735663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation for nonsteroidal anti-inflammatory drug-induced liver failure: nimesulide as the first implicated compound.
    Dastis SN; Rahier J; Lerut J; Geubel AP
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):919-22. PubMed ID: 18049158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Toxic hepatitis caused by nimesulide, presentation of a new case and review of the literature].
    Ferreiro C; Vivas S; Jorquera F; Domínguez AB; Espinel J; Muñoz F; Herrera A; Fernández MJ; Olcoz JL; Ortiz de Urbina J
    Gastroenterol Hepatol; 2000 Nov; 23(9):428-30. PubMed ID: 11126038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course and outcomes of drug-induced liver injury: nimesulide as the first implicated medication.
    Licata A; Calvaruso V; Cappello M; Craxì A; Almasio PL
    Dig Liver Dis; 2010 Feb; 42(2):143-8. PubMed ID: 19625223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nimesulide: 25 years later].
    Mattia C; Ciarcia S; Muhindo A; Coluzzi F
    Minerva Med; 2010 Aug; 101(4):285-93. PubMed ID: 21030939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nimesulide-induced hepatitis and acute liver failure.
    Weiss P
    Isr Med Assoc J; 1999 Nov; 1(3):221. PubMed ID: 10731347
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of nimesulide in patients with acetylsalicylic acid and nonsteroidal anti-inflammatory drug intolerance.
    Bavbek S; Celik G; Ediger D; Mungan D; Demirel YS; Misirligil Z
    J Asthma; 1999 Dec; 36(8):657-63. PubMed ID: 10609620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nimesulide: a lower risk treatment in rheumatic diseases].
    Trnavský K
    Vnitr Lek; 2004 Feb; 50(2):157-62. PubMed ID: 15077593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.